Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancers|October 2, 2019
c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial CarcinomaPie-Che Chen, Chih-Chia Yu, Wen-Yu Huang, et al.
Tzu Chi Medical Journal|October 18, 2024
Epigenetic modification in radiotherapy and immunotherapy for cancersShih-Kai Hung, Moon-Sing Lee, Wen-Yen Chiou, et al.
Frontiers in Cardiovascular Medicine|March 11, 2020
Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary CareMoon-Sing Lee, Dai-Wei Liu, Shih-Kai Hung, et al.
Cancer Cell International|November 11, 2024
Olaparib enhancing radiosensitization and anti-metastatic effect of oral cancer by targeting IL-17A signalChih-Chia Yu, Hon-Yi Lin, Michael W Y Chan, et al.
International Journal of Molecular Sciences|April 28, 2023
IRAK2, an Immune and Radiation-Response Gene, Correlates with Advanced Disease Features but Predicts Higher Post-Irradiation Local Control in Non-Metastatic and Resected Oral Cancer PatientsChih-Chia Yu, Hon-Yi Lin, Chen-Hsi Hsieh, et al.
Frontiers in Oncology|July 12, 2021
IRAK2, an IL1R/TLR Immune Mediator, Enhances Radiosensitivity via Modulating Caspase 8/3-Mediated Apoptosis in Oral Squamous Cell CarcinomaChih-Chia Yu, Michael W Y Chan, Hon-Yi Lin, et al.
Oral Oncology|December 19, 2012
Unexpected close surgical margin in resected buccal cancer: very close margin and DAPK promoter hypermethylation predict poor clinical outcomesHon-Yi Lin, Tze-Ta Huang, Moon-Sing Lee, et al.
Oncotarget|August 31, 2015
Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinomaChia-Ming Yeh, Pi-Che Chen, Hsiao-Yen Hsieh, et al.
Epigenetics|May 5, 2011
Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancerKun-Tu Yeh, Tze-Ho Chen, Hui-Wen Yang, et al.
Cancer Science|December 25, 2018
E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemnessFrank H C Cheng, Hon-Yi Lin, Tzy-Wei Hwang, et al.
Pageof 3